Oxford Target Therapeutics

Dr Maud Dumoux, the Franklin, and Dr Victor Bolanos-Garcia, Oxford Target Therapeutics.
#Breast cancer #Funding #Oncology #Oxford Target Therapeutics #Rosalind Franklin Institute

Cancer drug discovery company wins £50K research residency

Oxford Target Therapeutics, a company developing a promising therapy for triple negative breast cancer, is one of three UK life science companies awarded research prizes by the Rosalind Franklin Institute, based in Oxfordshire, UK. The prizes, awarded in collaboration with the Science and Technology Facilities Council… Read More

#News